What is the recommended dose of Flagyl (metronidazole) for bacterial vaginosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flagyl Dosing for Bacterial Vaginosis

For non-pregnant women with bacterial vaginosis, the recommended dose is metronidazole (Flagyl) 500 mg orally twice daily for 7 days. 1, 2, 3

Standard Treatment Regimens

Non-Pregnant Women

  • Oral metronidazole 500 mg twice daily for 7 days is the preferred systemic regimen 1, 2, 3
  • Alternative options include:
    • Metronidazole 0.75% vaginal gel, one applicatorful (5 g) intravaginally twice daily for 5 days 2, 3
    • Clindamycin 2% vaginal cream, one applicatorful at bedtime for 7 days 2, 3
    • Single 2-g oral dose of metronidazole (though this may have higher relapse rates) 4

Pregnant Women - High Risk

For women with prior preterm delivery, systemic therapy is essential to treat possible subclinical upper tract infections:

  • Metronidazole 250 mg orally three times daily for 7 days is the recommended regimen 5, 3
  • This lower dose minimizes fetal exposure while providing systemic coverage 5
  • Alternative: metronidazole 2 g single dose or clindamycin 300 mg orally twice daily for 7 days 5

Pregnant Women - Low Risk

For symptomatic women without prior preterm delivery:

  • Metronidazole 250 mg orally three times daily for 7 days 5, 3
  • Alternatives include metronidazole 2 g single dose, clindamycin 300 mg twice daily for 7 days, or metronidazole gel 0.75% intravaginally twice daily for 5 days 5
  • Avoid clindamycin vaginal cream in pregnancy as randomized trials showed increased preterm deliveries 5

Critical Patient Counseling Points

Alcohol Avoidance

  • Patients must completely avoid all alcoholic beverages during treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions 1

Partner Treatment

  • Sex partners do not require treatment for bacterial vaginosis, as multiple trials show treating partners does not improve cure rates or prevent recurrence 1
  • This distinguishes BV from sexually transmitted infections 1, 2

Expected Side Effects

  • Mild gastrointestinal upset and metallic taste are common 1
  • These effects are significantly reduced with vaginal gel formulations, which achieve less than 2% of oral blood levels 1

Special Considerations

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients 5

Contraceptive Interactions

  • Clindamycin vaginal cream weakens latex condoms and diaphragms 1
  • Metronidazole gel does not have this interaction 1

Follow-Up and Recurrence

  • No follow-up visit is necessary if symptoms completely resolve 1
  • Recurrence is common, with up to 50% of women experiencing BV again within one year 1
  • If symptoms return, retreatment with a recommended regimen is appropriate 1
  • Avoid self-treatment with over-the-counter products 1

Common Pitfalls to Avoid

  • Do not confuse BV dosing (500 mg twice daily for 7 days) with trichomoniasis dosing (2 g single dose or 500 mg twice daily for 7 days) 6, 1
  • Do not use the single 2-g dose as first-line for BV, as it may have higher relapse rates compared to the 7-day regimen 4
  • In pregnancy, use the lower 250 mg three times daily dose rather than the standard 500 mg twice daily to minimize fetal exposure 5, 3
  • Remember that vaginal preparations are less effective than oral therapy for treating potential upper tract involvement 3

References

Guideline

Bacterial Vaginosis Treatment with Metronidazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial vaginosis.

Primary care update for Ob/Gyns, 2000

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Treatment of sexually transmitted vaginosis/vaginitis.

Reviews of infectious diseases, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.